CD8A and neoplasm: Previous studies on tumor therapeutic models reported that administration of tumor antigen (e.g., melanoma-associated antigen recognized by T cells-1 and Wilms’ tumor 1 (WT1))-expressing aAVCs induced potent CD4+ and CD8+ T cell responses [63,64,65].